Start shopping and find your next favourite medicine.
Browse Catalog
Icosapent Ethyl 1000 mg Capsules contain a highly purified form of eicosapentaenoic acid (EPA), an omega-3 fatty acid used to lower elevated triglyceride levels and reduce cardiovascular risk in selected patients. Unlike standard fish oil supplements, prescription Icosapent Ethyl is highly concentrated, purified, and clinically studied for heart protection alongside statin therapy.
Most people assume all omega-3 products are essentially the same.
They are not.
Walk into any supplement store and you’ll find hundreds of fish oil products. Most contain varying amounts of EPA and DHA, inconsistent purity levels, and little clinical evidence for cardiovascular outcomes.
Icosapent Ethyl is different.
It contains a highly purified ethyl ester form of EPA specifically developed for prescription use.
Its primary purpose is not general wellness.
It is used to lower elevated triglyceride levels and help reduce cardiovascular risk in patients who remain at risk despite statin treatment.
This distinction explains why cardiologists often view prescription EPA therapy very differently from over-the-counter fish oil supplements.
Triglycerides are a type of fat circulating in the bloodstream.
When triglyceride levels become elevated, cardiovascular risk often rises alongside them.
Icosapent Ethyl works through multiple mechanisms:
What makes Icosapent Ethyl unique is that it contains EPA without DHA.
Some researchers believe this EPA-only approach contributes to its cardiovascular benefits without some of the lipid effects seen with mixed omega-3 formulations.
Doctors commonly prescribe Icosapent Ethyl for:
It is typically used alongside dietary modification, exercise, and standard cardiovascular medications rather than replacing them.
| Condition | Clinical Purpose |
|---|---|
| Hypertriglyceridemia | Lower triglyceride levels |
| Severe Hypertriglyceridemia | Reduce elevated blood fats |
| Cardiovascular Risk Reduction | Lower risk of cardiovascular events |
| Coronary Artery Disease | Adjunctive therapy |
| Mixed Dyslipidemia | Lipid management support |
| High-Risk Diabetes | Cardiovascular protection |
For years, omega-3 supplements generated enthusiasm but inconsistent clinical results.
The question wasn’t whether omega-3 fatty acids were beneficial.
The question was whether they could meaningfully reduce major cardiovascular events.
Prescription Icosapent Ethyl changed that conversation.
Large cardiovascular outcome studies showed reductions in major adverse cardiovascular events among selected high-risk patients receiving EPA therapy alongside statins.
That finding helped move Icosapent Ethyl from a triglyceride-lowering drug into a broader cardiovascular risk-reduction discussion.
It remains one of the few omega-3 therapies with substantial cardiovascular outcome data behind it.
| Strength | Common Clinical Use |
|---|---|
| 1000 mg Capsule | Standard prescription strength |
| 2 g Twice Daily | Common adult regimen |
| Individualized | Based on physician assessment |
Always follow the dosing schedule prescribed by your healthcare provider.
| Attribute | Details |
|---|---|
| Generic Name | Icosapent Ethyl |
| Popular Brand | Vascepa® |
| Strength | 1000 mg |
| Dosage Form | Capsule |
| Drug Class | Omega-3 Fatty Acid Derivative |
| Route | Oral |
| Used For | Hypertriglyceridemia & Cardiovascular Risk Reduction |
No. Icosapent Ethyl is a purified prescription EPA product. Standard fish oil supplements typically contain varying amounts of EPA and DHA and are not equivalent.
Vascepa® is the branded version of Icosapent Ethyl and is used to lower triglycerides and reduce cardiovascular risk in selected patients.
Yes. Lowering elevated triglyceride levels is one of its primary approved uses.
Clinical studies have shown reductions in major cardiovascular events among selected high-risk patients receiving prescription EPA therapy alongside statins.
No. It is an omega-3 fatty acid derivative and is often used together with statins rather than replacing them.
Many patients take Icosapent Ethyl as part of long-term cardiovascular risk management under physician supervision.
Yes. High-risk diabetic patients with elevated triglycerides are among the groups frequently prescribed Icosapent Ethyl.
Answer: Yes. We supply Icosapent Ethyl Capsules to eligible international destinations, subject to local regulations and product availability.
Answer: Icosapent Ethyl is the active ingredient found in Vascepa® and equivalent prescription EPA formulations.
Answer: Products are supplied in manufacturer-sealed pharmaceutical packaging with batch details and expiry information.
Answer: No. It is generally prescribed alongside statins and other cardiovascular treatments rather than replacing them.
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Reviews
There are no reviews yet